SOX2-dependent expression of dihydroorotate dehydrogenase regulates oral squamous cell carcinoma cell proliferation

Abstract

Oral squamous cell carcinoma (OSCC) become a heavy burden of public health, with approximately 300 000 newly diagnosed cases and 145 000 deaths worldwide per year. Nucleotide metabolism fuel DNA replication and RNA synthesis, which is indispensable for cell proliferation. But how tumor cells orchestrate nucleotide metabolic enzymes to support their rapid growth is largely unknown. Here we show that expression of pyrimidine metabolic enzyme dihydroorotate dehydrogenase (DHODH) is upregulated in OSCC tissues, compared to non-cancerous adjacent tissues. Enhanced expression of DHODH is correlated with a shortened patient survival time. Inhibition of DHODH by either shRNA or selective inhibitors impairs proliferation of OSCC cells and growth of tumor xenograft. Further, loss of functional DHODH imped de novo pyrimidine synthesis, and disrupt mitochondrial respiration probably through destabilizing the MICOS complex. Mechanistic study shows that transcriptional factor SOX2 plays an important role in the upregulation of DHODH in OSCC. Our findings add to the knowledge of how cancer cells co-opt nucleotide metabolism to support their rapid growth, and thereby highlight DHODH as a potential prognostic and therapeutic target for OSCC treatment.

References

[1] Chandler KB, . β-Catenin/CBP inhibition alters epidermal growth factor receptor fucosylation status in oral squamous cell carcinoma. Mol. Omics, 2020, 16: 195-209.

[2] Chi AC, Day TA, Neville BW. Oral cavity and oropharyngeal squamous cell carcinoma–an update. CA Cancer J. Clin., 2015, 65: 401-421.

[3] Kato MG, . Update on oral and oropharyngeal cancer staging - International perspectives. World J. Otorhinolaryngol. Head. Neck Surg., 2020, 6: 66-75.

[4] Chen X, . Zymosan promotes proliferation, Candida albicans adhesion and IL-1β production of oral squamous cell carcinoma in vitro. Infect. Agent Cancer, 2020, 15

[5] Abbas H. First-principles study of interaction of serine with nucleobases of DNA and RNA. J. Biol. Phys., 2017, 43: 105-111.

[6] Löffler M, Jöckel J, Schuster G, Becker C. Dihydroorotat-ubiquinone oxidoreductase links mitochondria in the biosynthesis of pyrimidine nucleotides. Mol. Cell Biochem., 1997, 174: 125-129.

[7] Zhang Y, . Transition state analogues of Plasmodium falciparum and human orotate phosphoribosyltransferases. J. Biol. Chem., 2013, 288: 34746-34754.

[8] Löffler, M., Carrey, E. A. & Knecht, W. The pathway to pyrimidines: the essential focus on dihydroorotate dehydrogenase, the mitochondrial enzyme coupled to the respiratory chain. Nucleosides Nucleotides Nucleic Acids 39, 1–25 (2020).

[9] Yin S, Kabashima T, Zhu Q, Shibata T, Kai M. Fluorescence assay of dihydroorotate dehydrogenase that may become a cancer biomarker. Sci. Rep., 2017, 7

[10] Villa, E., Ali, E. S., Sahu, U. & Ben-Sahra, I. Cancer Cells Tune the Signaling Pathways to Empower de Novo Synthesis of Nucleotides. Cancers (Basel) 11, https://doi.org/10.3390/cancers11050688 (2019).

[11] Oliver JD, . F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenase. Proc. Natl Acad. Sci. USA, 2016, 113: 12809-12814.

[12] Christian S, . The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies. Leukemia, 2019, 33: 2403-2415.

[13] Muehler A, Kohlhof H, Groeppel M, Vitt D. Safety, Tolerability and Pharmacokinetics of Vidofludimus calcium (IMU-838) After Single and Multiple Ascending Oral Doses in Healthy Male Subjects. Eur. J. Drug Metab. Pharmacokinetics, 2020, 45: 557-573.

[14] Santoro V, . SLC25A32 sustains cancer cell proliferation by regulating flavin adenine nucleotide (FAD) metabolism. Oncotarget, 2020, 11: 801-812.

[15] Squadrito F, . Pharmacological activity and clinical use of PDRN. Front Pharm., 2017, 8: 224.

[16] Kozjak-Pavlovic V. The MICOS complex of human mitochondria. Cell Tissue Res., 2017, 367: 83-93.

[17] Rampelt H, Zerbes RM, van der Laan M, Pfanner N. Role of the mitochondrial contact site and cristae organizing system in membrane architecture and dynamics. Biochim Biophys. Acta Mol. Cell Res., 2017, 1864: 737-746.

[18] Fang J, . Dihydro-orotate dehydrogenase is physically associated with the respiratory complex and its loss leads to mitochondrial dysfunction. Biosci. Rep., 2013, 33

[19] Turatti, E., da Costa Neves A., Fau - de Magalhães, M. H. C. G., de Magalhães Mh Fau - de Sousa, S. O. M. & de Sousa, S. O. Assessment of c-Jun, c-Fos and cyclin D1 in premalignant and malignant oral lesions.

[20] Kokalj Vokač N, Cizmarević B, Zagorac A, Zagradišnik B, Lanišnik B. An evaluation of SOX2 and hTERC gene amplifications as screening markers in oral and oropharyngeal squamous cell carcinomas. Mol. Cytogenet., 2014, 7: 5.

[21] Pallavi N, Nalabolu GRK, Hiremath SKS. Bcl-2 and c-Myc expression in oral dysplasia and oral squamous cell carcinoma: An immunohistochemical study to assess tumor progression. J. Oral. Maxillofac. Pathol., 2018, 22: 325-331.

[22] Robinson, A. D., Eich, M. L. & Varambally, S. Dysregulation of de novo nucleotide biosynthetic pathway enzymes in cancer and targeting opportunities.

[23] Yeo KL, . Synergistic suppression of dengue virus replication using a combination of nucleoside analogs and nucleoside synthesis inhibitors. Antimicrob. Agents Chemother., 2015, 59: 2086-2093.

[24] Cha YH, Yook JI, Kim HS, Kim NH. Catabolic metabolism during cancer EMT. Arch. Pharm. Res., 2015, 38: 313-320.

[25] Lütje S, . PSMA ligands for radionuclide imaging and therapy of prostate cancer: clinical status. Theranostics, 2015, 5: 1388-1401.

[26] Mok WK, Tan YX, Lee J, Kim J, Chen WN. A metabolomic approach to understand the solid-state fermentation of okara using Bacillus subtilis WX-17 for enhanced nutritional profile. AMB Express, 2019, 9

[27] Tang J, . Sam50-Mic19-Mic60 axis determines mitochondrial cristae architecture by mediating mitochondrial outer and inner membrane contact. Cell Death Differ., 2020, 27: 146-160.

[28] Stephan T, . MICOS assembly controls mitochondrial inner membrane remodeling and crista junction redistribution to mediate cristae formation. EMBO J., 2020, 39

[29] Novak, D. et al. SOX2 in development and cancer biology. Semin Cancer Biol. https://doi.org/10.1016/j.semcancer.2019.08.007 (2019).

[30] Freier K, . Recurrent copy number gain of transcription factor SOX2 and corresponding high protein expression in oral squamous cell carcinoma. Genes Chromosomes Cancer, 2010, 49: 9-16.

[31] Liang X, . Combined class I histone deacetylase and mTORC1/C2 inhibition suppresses the initiation and recurrence of oral squamous cell carcinomas by repressing SOX2. Cancer Lett., 2019, 454: 108-119.

[32] Oh JY, Park MA, Kim YC. Peppermint oil promotes hair growth without toxic signs. Toxicol. Res., 2014, 30: 297-304.

[33] Yin, S., Kabashima, T., Zhu, Q., Shibata, T. & Kai, M. Fluorescence assay of dihydroorotate dehydrogenase that may become a cancer biomarker. Sci. Rep. 7, 40670 (2017).

Funding

National Natural Science Foundation of China (National Science Foundation of China)(81672674)